Innovent HK IPO gains wide support from international investors; Spearheads in cancer treatment breakthroughs BioTech November 1, 2018 HONG KONG – (ACN Newswire) – Chinese biologic drug developer Innovent Biologics (Innovent) becomes the 4th pre-revenue biotech firm to list in Hong…
